This inventor holds 1 USPTO granted patent. Top assignee: Elitra Pharmaceuticals Inc.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Jamie M Froelich: Innovator in Microbial Proliferation
Introduction
Jamie M Froelich is a notable inventor based in San Diego, California. He has made significant contributions to the field of microbiology, particularly in understanding the proliferation of Escherichia coli. His work has implications for drug discovery and antimicrobial research.
Latest Patents
Froelich holds a patent titled "Genes identified as required for proliferation in Escherichia coli." This patent discloses the sequences of nucleic acids encoding proteins essential for the proliferation of E. coli. The nucleic acids can be utilized to express proteins or portions thereof, which can lead to the development of antibodies that specifically bind to these proteins. Additionally, these nucleic acids can be employed in rational drug discovery programs and to design expression and secretion vectors. They also have applications in various assay systems to screen for proliferation-required genes in other organisms and to identify antimicrobial agents.
Career Highlights
Froelich's career is marked by his innovative research and contributions to the scientific community. His work at Elitra Pharmaceuticals Inc. has positioned him as a key figure in the development of new methodologies for drug discovery and microbial research.
Collaborations
Throughout his career, Froelich has collaborated with esteemed colleagues, including Judith W Zyskind and Kari Lynn Ohlsen. These collaborations have enhanced the scope and impact of
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile